Insider Transactions in Q2 2025 at Neurocrine Biosciences Inc (NBIX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 27
2025
|
Kevin Charles Gorman Director |
SELL
Open market or private sale
|
Direct |
9,613
-1.83%
|
$1,153,560
$120.38 P/Share
|
|
May 22
2025
|
William H Rastetter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,869
+6.64%
|
-
|
|
May 22
2025
|
Christine A Poon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,435
+50.0%
|
-
|
|
May 22
2025
|
Stephen A Sherwin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,869
+17.48%
|
-
|
|
May 22
2025
|
Shalini Sharp Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,435
+37.14%
|
-
|
|
May 22
2025
|
George J Morrow Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,869
+28.87%
|
-
|
|
May 22
2025
|
Richard F Pops Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,869
+7.68%
|
-
|
|
May 22
2025
|
Gary A Lyons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,435
+1.18%
|
-
|
|
May 22
2025
|
Johanna Mercier Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,435
+28.87%
|
-
|
|
May 22
2025
|
Leslie V Norwalk Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,435
+37.14%
|
-
|
|
May 16
2025
|
Julie Cooke Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,468
+19.41%
|
$394,548
$61.82 P/Share
|
|
May 05
2025
|
William H Rastetter Director |
SELL
Open market or private sale
|
Direct |
30,000
-44.45%
|
$3,300,000
$110.2 P/Share
|
|
May 05
2025
|
William H Rastetter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+30.77%
|
$1,260,000
$42.76 P/Share
|